Cargando…
Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation
BACKGROUND: Tumor angiogenesis is regarded as a rational anti-cancer target. The efficacy and indications of anti-angiogenic therapies in clinical practice, however, are relatively limited. Therefore, there still exists a demand for revealing the distinct characteristics of tumor endothelium that is...
Autores principales: | Quan, Lili, Ohgaki, Ryuichi, Hara, Saori, Okuda, Suguru, Wei, Ling, Okanishi, Hiroki, Nagamori, Shushi, Endou, Hitoshi, Kanai, Yoshikatsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702703/ https://www.ncbi.nlm.nih.gov/pubmed/33256804 http://dx.doi.org/10.1186/s13046-020-01762-0 |
Ejemplares similares
-
Proteomics and phosphoproteomics reveal key regulators associated with cytostatic effect of amino acid transporter LAT1 inhibitor
por: Okanishi, Hiroki, et al.
Publicado: (2020) -
Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse models
por: Shi, Zitong, et al.
Publicado: (2023) -
Pharmacologic inhibition of LAT1 predominantly suppresses transport of large neutral amino acids and downregulates global translation in cancer cells
por: Nishikubo, Kou, et al.
Publicado: (2022) -
Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells
por: Nishikubo, Kou, et al.
Publicado: (2023) -
Specific transport of 3‐fluoro‐l‐α‐methyl‐tyrosine by LAT1 explains its specificity to malignant tumors in imaging
por: Wei, Ling, et al.
Publicado: (2016)